Pérez NM, Rodríguez HY, Suárez PY

Language: Spanish
References: 10
Page: 199-212
PDF size: 225.23 Kb.

ABSTRACT

Introduction: quinolones are a group of antimicrobials of high clinical significance. Ciprofloxacin hydrochloride monohydrate is a second-generation antibacterial fluoroquinolone for treatment of several infections and is marketed as eye drops, injections, capsule and tablets.
Objective: to develop and to validate an ultraviolet spectrophotometric analytical method to be used in the quality control of ciprofloxacin hydrochloride monohydrate in newly manufactured Ciprecu tablets.
Methods: this method was devised at the laboratory and thoroughly validated pursuant to the category I parameters. The method was selected on account of the existence of chromophore groups in the structure of the analyzed compound. The maximum absorption wavelength was set at 273 nm of 5 µg/mL in 0.1 mol/L hydrochloric acid.
Results: based on the validation process, it was demonstrated that this method has adequate specificity against the study matrix components, as well as its linearity, accuracy and precision in the range of 2.5 to 7.5 µg/mL. The results of the application of this method were similar to those of the official procedure suggested for the same purposes in USP 33, 2010.
Conclusions: The analytical method was valid for the suggested purposes, so it is a new simple, rapid and economic alternative for the quality control of Ciprofloxacin hydrochloride in Ciprecu tablets.

REFERENCES

1. Beltrán JL, Jiménez-Lozano E, Barrón D, Barbosa J. Determination of quinolone antimicrobial agents in strongly overlapped peaks from capillary electrophoresis using multivariate calibration methods. Analyt Chim Acta. 2004;501:137-41.

2. Ministerio de Salud Pública. Centro para el Desarrollo de la Farmacoepidemiología. Formulario Nacional de Medicamentos. Quinolonas, antisépticos y antiinfecciosos. La Habana: Ed. Ciencias Médicas; 2006. p. 135-6.

3. Mediavilla A, Flórez J. Enfermedades infecciosas. Farmacología humana. 3ra ed. Barcelona: Masson SA; 1997. p 1145, 1151.

4. British Pharmacopoeia. Medicinal and Pharmaceutical Substances. London: The Stationery Office; 2009.

5. The United Stated Pharmacopoeia 33 and National Formulary 28 (USP33-NF28). Washington: The United States Pharmacopeial Convention, Inc; 2010.

6. De Witte B, Dewulf J, Demeestere K, De Ruyck M, Van Langenhove H. Critical points in the analysis of ciprofloxacin by high-performance liquid chromatography. J Chromatogr A. 2007;1140:126-30.

7. Adhoum N, Monser L, Toumi M, Boujlel K, Pascual MI, Pérez G, et al. Solid-phase UV spectrophotometric method for determination of ciprofloxacin. Microchem J. 2004;77:79-84.

8. Suna J, Sakaia S, Tauchia Y, Deguchia Y, Chenb J, Zhangb R, et al. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium. Eur J Pharmaceut Biopharmaceut. 2002;54:51-8.

9. Liua B, Wang DJ, Wang X, Liu BM, Kong YM, Hea LL, et al. Spectroscopic investigation on protein damage by ciprofloxacin under ultrasonic irradiation. Spectrochimica Acta. 78;2011:712-7.

10. Regulación 41. Validación de métodos analíticos. Centro para el Control Estatal de la Calidad de los Medicamentos (CECMED). Ministerio de Salud Pública. La Habana, Cuba. 2007.